Mikio Masada

1.7k total citations
77 papers, 1.3k citations indexed

About

Mikio Masada is a scholar working on Pharmacology, Oncology and Pharmacology. According to data from OpenAlex, Mikio Masada has authored 77 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Pharmacology, 19 papers in Oncology and 19 papers in Pharmacology. Recurrent topics in Mikio Masada's work include Antibiotics Pharmacokinetics and Efficacy (13 papers), Pharmacy and Medical Practices (12 papers) and Drug Transport and Resistance Mechanisms (11 papers). Mikio Masada is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (13 papers), Pharmacy and Medical Practices (12 papers) and Drug Transport and Resistance Mechanisms (11 papers). Mikio Masada collaborates with scholars based in Japan and New Zealand. Mikio Masada's co-authors include TANEKAZU NADAI, Kunio Nakanishi, Yoshihiko Nishio, Noboru Toda, Ryuichi Kikkawa, Yuichi Yoshida, Tomonori Okamura, Atsunori Kashiwagi, Kazuya Shinozaki and Toyozo Uno and has published in prestigious journals such as The Science of The Total Environment, Diabetes and Journal of Chromatography A.

In The Last Decade

Mikio Masada

69 papers receiving 1.3k citations

Peers

Countries citing papers authored by Mikio Masada

Since Specialization

Citations

This map shows the geographic impact of Mikio Masada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mikio Masada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mikio Masada more than expected).

Fields of papers citing papers by Mikio Masada

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mikio Masada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mikio Masada. The network helps show where Mikio Masada may publish in the future.

Co-authorship network of co-authors of Mikio Masada

This figure shows the co-authorship network connecting the top 25 collaborators of Mikio Masada. A scholar is included among the top collaborators of Mikio Masada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mikio Masada. Mikio Masada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Detection of pharmaceuticals and phytochemicals together with their metabolites in hospital effluents in Japan, and their contribution to sewage treatment plant influents 2016 ·The Science of The Total Environment ·Takashi Azuma, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Yoshiki Mino, Tetsuya Hayashi, Yoshikazu Fujita, Mikio Masada	108
2	Clinical effect of a multidisciplinary team approach to the initial treatment of patients with hospital-acquired bloodstream infections at a Japanese university hospital 2014 ·American Journal of Infection Control ·(unknown), (unknown), Toshiaki Nakamura, Ryoichi Yano, (unknown), (unknown), Satoshi Ikegaya, Hiromichi Iwasaki, Mikio Masada	13
3	Variations in the Blood Phenytoin Levels during Long-Term Combined Treatment with S-1 and Phenytoin 2014 ·Case Reports in Oncology ·(unknown), (unknown), Hiroaki Matsuoka, Kyohei Watanabe, (unknown), Yuichiro Kayano, Ryoichi Yano, Toshiaki Nakamura, Mikio Masada	2
4	Proposal for the Best Pharmacovigilance Plan in Japan by comparing Japan Postmarketing Studies to the U.S. Postmarketing Requirements: 2012 ·(unknown), (unknown), Shigeru Kageyama, Kiyoshi Kubota, Kiichiro Tsutani, (unknown), (unknown), Mikio Masada, (unknown)	2
5	Pharmacists’ Knowledge and Opinions Regarding Generic Drugs: A Survey 2010 ·(unknown), (unknown), Junji Ito, (unknown), Nobuyuki Goto, Masayuki Nadai, Mikio Masada	0
6	Monitoring of Leukocyte Counts to Help Ensure Proper Use of Anticancer Drugs in Patients with Solid Tumors 2008 ·Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences) ·(unknown), Ryoichi Yano, (unknown), Kyohei Watanabe, (unknown), (unknown), Toshiaki Nakamura, (unknown), Nobuyuki Goto, Teruyoshi Yokoyama, Mikio Masada	1
7	Questionnaire Survey on Efficacy and Safety of the Oral Neuraminidase Inhibitor Oseltamivir (Tamiflu) in Treatment of Influenza (2006 flu Season) 2007 ·Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences) ·(unknown), (unknown), Kyohei Watanabe, (unknown), (unknown), Nobuyuki Goto, Mikio Masada, Etsuko Miyamoto	0
8	Evaluation of Generic Drugs Using Intra-Individual Variation Index 2006 ·Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences) ·Kyohei Watanabe, Toshiaki Nakamura, (unknown), (unknown), Nobuyuki Goto, Mikio Masada	1
9	Variation in Biological Equivalency Tests among Generic Drugs 2005 ·Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences) ·Toshiaki Nakamura, (unknown), (unknown), Nobuyuki Goto, (unknown), Mikio Masada	9
10	Clinical Evaluation of Early Post-Marketing Phase Vigilance-Features of Adverse Events Noted in Early Post-marketing Phase Vigilance- 2005 ·Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences) ·(unknown), Nobuyuki Goto, Yuichiro Kayano, (unknown), (unknown), Ryoichi Yano, Kyohei Watanabe, (unknown), (unknown), Sadaaki Maeda, Mikio Masada	0
11	2004 ·Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics ·Ryoichi Yano, Toshiaki Nakamura, (unknown), Mikio Masada	5
12	A Drug Utilization Study on Pharmaceutical Preparations for Scabies: The Prevalence of Scabies and its Management. 2003 ·Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences) ·Nobuyuki Goto, (unknown), Tadashi Shiraishi, (unknown), (unknown), Tadashi Sugiyama, (unknown), Mikio Masada	0
13	Sequence Variability and Candidate Gene Analysis in Two Cancer Patients with Complex Clinical Outcomes During Morphine Therapy 2003 ·Drug Metabolism and Disposition ·Takeshi Hirota, Ichiro Ieiri, Hiroshi Takane, Hiroyuki Sano, (unknown), (unknown), Akira Yamasaki, Hiromi Takeuchi, Mikio Masada, Eiji Shimizu, Shun Higuchi, Kenji Otsubo	72
14	Clinical Use of Drug Delivery Systems: Prescription Survey on Clinical Use of PGE1 in Lipid Emulsions with Aqueous Infusions. 1999 ·Japanese Journal of Hospital Pharmacy ·(unknown), Yuji Kurosaki, Keita Yamauchi, (unknown), Hiroaki Araki, Yutaka Gomita, Nobuyuki Goto, Mikio Masada, Hiromu Kawasaki	1
15	A Drug Utilization Study on Off-Label Uses 1999 ·Nobuyuki Goto, Kazuo Sato, (unknown), (unknown), Mikio Masada, (unknown), Yoshihiro Katagiri, Masahiro Nakano, (unknown), (unknown), SHIKIFUMI KITAZAWA	0
16	Influence of Type of Questionnaire on the Prevalence of Coughing in Patients Taking Angiotensin Converting Enzyme Inhibitors(ACEI). 1996 ·Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics ·Nobuyuki Goto, (unknown), (unknown), Mikio Masada, Jong‐Dae Lee, Akiyoshi Tsubokawa, Hiromasa Shimizu, Takanori Ueda, Tõru Nakamura, SHIKIFUMI KITAZAWA	2
17	Improvement of the Rectal Bioavailability of Latamoxef Sodium by Adjuvants Following Administration of a Suppository. 1994 ·Biological and Pharmaceutical Bulletin ·Kunio Nakanishi, Tohru Masukawa, Mikio Masada, TANEKAZU NADAI	8
18	Effect of Cyclodextrins on Biological Membrane. II. Mechanism of Enhancement on the Intestinal Absorption of Non-absorbable Drug by Cyclodextrins. 1992 ·Chemical and Pharmaceutical Bulletin ·Kazuki Nakanishi, TANEKAZU NADAI, Mikio Masada, Kumiko Miyajima	35
19	Effect of Adjuvants on Charge-Selective Permeability and Electrical Resistance of Rat Jejunal Membrane 1990 ·Journal of Pharmaceutical Sciences ·(unknown), Mikio Masada, TANEKAZU NADAI, Toshikiro Kimura	14
20	EFFECT OF PHARMACEUTICAL ADJUVANTS ON THE RECTAL PERMEABILITY OF DRUGS 1983 ·Journal of Pharmacobio-Dynamics ·Kunio Nakanishi, (unknown), Shinji Yamashita, Mikio Masada, TANEKAZU NADAI	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact